3 ca jobs found

Associate Director, Field Medical Director Ophthalmology North America West At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of-concept data in Guillain-Barr syndrome, Huntington's disease and geographic atrophy, we are rigorously advancing our mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon, you'll be part of a team committed to making an impact together. We're seeking exceptional talent from all backgrounds to fuel our growth. At Annexon, we're...

Job Description Job Description Salary: $30-40 hourly DOE Established Ventura County Ophthalmology Practice is seeking an experienced Full-Time, In-House Medical Biller with strong ophthalmology and Medi-Cal expertise. This is an on-site position (not remote). We are looking for a highly detail-oriented, results-driven professional with a minimum of3+ years of medical billing experience, preferably in ophthalmology or a surgical specialty. Required Experience & Skills: Hands-on experience with Medi-Cal/Medicaid claims submission Denials management and appeals AR follow-up and persistent payer follow-up Insurance eligibility verification Strong knowledge of CPT, ICD-10, modifiers, global periods, and surgical billing Experience with AdvancedMD practice management/billing software Ability to independently manage accounts receivable and improve collections performance Experience reviewing payer contracts and reimbursement schedules Understanding of fee...

Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of concept data in Guillain-Barré syndrome, Huntington's disease and geographic atrophy, we are rigorously advancing our mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon, you'll be part of a team committed to making an impact together. For more information on Annexon and our pipeline, check out our site Annexon Biosciences & Annexon Pipeline. We trade on Nasdaq under the ticker symbol...